(Q34002989)

30 July 2017

1 reference

title

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? (English)

1 reference

30 July 2017

0 references

Patrick G Kehoe

1

1 reference

30 July 2017

Gordon K Wilcock

series ordinal

2

1 reference

30 July 2017

publication date

1 April 2007

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

373-378

1 reference

Hypertension, hypertension-clustering factors and Alzheimer's disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Incidence of hypertension in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Potential for antihypertensive treatment with an AT(1)-receptor blocker to reduce dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Cardiovascular risk factors and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Identification of angiotensin II receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Preliminary biochemical characterization of two angiotensin II receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Review: Potential of renin inhibition in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Dual ACE and neutral endopeptidase inhibitors: novel therapy for patients with cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Prevention of dementia: lessons from SYST-EUR and PROGRESS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Prevention of dementia and cerebroprotection with antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

The renin-angiotensin-aldosterone system and Alzheimer s disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

The role of the brain renin-angiotensin system in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Haplotypes extending across ACE are associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Synaptic targeting by A beta oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

Angiotensin peptides and their pleiotropic actions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970077-7

7 January 2021

10.1016/S1474-4422(07)70077-7

Identifiers

DOI

1 reference

30 July 2017

1 reference